Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).

被引：0
|
作者：
Puerto, VL
Cardenas, J
Lara, F
Goana, R
Silva, A
Barroso, N
机构：
[1] IMSS CMN Siglo XXI, Mexico City, DF, Mexico
[2] Ctr Estatal Cancerol, Colima, Mexico
[3] INCAN, Tlalpan, Mexico
[4] Hosp Gen Dr M Silva, Morelia, Michoacan, Mexico
[5] Hosp Dr A Leano, Zapopan, Mexico
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
512
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [41] A Phase 11 study of neoadjuvant chemotherapy (NC) with taxotere, adriamycin and cyclophosphamide (TAC) in locally advanced breast cancer (LABC)
    Lal, A.
    Alidina, A.
    Vaziri, I.
    EJC SUPPLEMENTS, 2005, 3 (02): : 122 - 122
  • [42] FDG PET can be useful to predict survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer (LABC)
    Rousseau, C.
    Campion, L.
    Pallardy, A.
    Campone, M.
    Testard, A.
    Ferrer, L.
    Bridji, B.
    Kraeber-Bodere, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S246 - S247
  • [43] FUNCTIONAL IMAGING OF NEOADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY IN WOMEN WITH LOCALLY ADVANCED BREAST CANCER (LABC) USING DIFFUSE OPTICAL SPECTROSCOPY
    Soliman, H.
    Gunasekara, A.
    Rycroft, M.
    Zubovits, J.
    Dent, R.
    Spayne, J.
    Yaffe, M.
    Czarnota, G.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S14 - S14
  • [44] Neoadjuvant dose dense chemotherapy alternating gemcitabine (G) plus docetaxel (D) and vinorelbine (V) plus epirubicin (E) in locally advanced non inflammatory breast carcinoma (LABC): a phase II study
    Levy, E
    Jenabian, A
    Scotte, F
    Lecuru, F
    Lefrere-Belda, MA
    Hoffman, H
    Eme, D
    Rideller, K
    Medioni, J
    Andrieu, JM
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S231 - S232
  • [45] Increased feasibility of weekly epirubicin and paclitaxel as neoadjuvant chemotherapy for locally advanced breast carcinoma
    Chen, SC
    Chang, HK
    Lin, YC
    Cheung, YC
    Tsai, CS
    Leung, WM
    Hsueh, S
    Chen, MF
    ONKOLOGIE, 2005, 28 (6-7): : 339 - 344
  • [46] Prediction of response of locally advanced breast cancer (LABC) to neoadjuvant anthracycline chemotherapy using 99mTc-sestamibi.
    Ang, P
    Balram, C
    Tan, PH
    Ang, EES
    Ong, SC
    Wong, ZW
    Lim, E
    Zhou, QY
    Ho, GH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 159S - 159S
  • [47] Response rate with weekly epirubicin and docetaxel as neoadjuvant chemotherapy (NAC) for locally-advanced breast cancer (BC).
    Chen, SC
    Chang, HK
    Lin, YC
    Leung, WM
    Chang, JT
    Cheung, YC
    Hsueh, S
    Lo, YF
    Tsai, HP
    Chen, MF
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 99S - 99S
  • [48] Plasma and tissue pharmacokinetics of epirubicin and paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancer
    Hunz, M.
    Jetter, A.
    Warm, M.
    Pantke, E.
    Tuscher, M.
    Hempel, G.
    Jaehde, U.
    Untch, M.
    Kurbacher, C.
    Fuhr, U.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) : 659 - 668
  • [49] A phase II trial of docetaxel (taxotere) in combination with epirubicin as neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Fried, G
    Zidan, J
    Epelbaum, R
    Keren-Rosenberg, S
    Basher, W
    Steckelman, I
    Kogan, F
    Haim, N
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S69 - S70
  • [50] Clinical outcome of locally advanced breast cancer (LABC) treated with neoadjuvant chemotherapy (NA-CT):: A phase II trial -: Epirubicin (E), cyclophosphamide (C), and paclitaxel (T)
    Broco, Sofia
    Sousa, Gabriela
    Carvalho, Teresa
    Albano, Jose
    Raimundo, Dulce
    Abraul, Elsa
    Gervasio, Helena
    Oliveira, Carlos
    ANNALS OF ONCOLOGY, 2006, 17 : 97 - 97
12345